Spectaire (SPEC) Competitors $0.0010 0.00 (0.00%) As of 04/8/2025 12:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock SPEC vs. THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, FTV, and VLTOShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Fortive Veralto Spectaire (NASDAQ:SPEC) and ThermoGenesis (NASDAQ:THMO) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, community ranking, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership. Which has preferable valuation and earnings, SPEC or THMO? Spectaire has higher earnings, but lower revenue than ThermoGenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/AThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Does the MarketBeat Community favor SPEC or THMO? ThermoGenesis received 26 more outperform votes than Spectaire when rated by MarketBeat users. Likewise, 60.47% of users gave ThermoGenesis an outperform vote while only 0.00% of users gave Spectaire an outperform vote. CompanyUnderperformOutperformSpectaireOutperform VotesNo VotesUnderperform Votes1100.00% ThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% Do institutionals and insiders have more ownership in SPEC or THMO? 26.5% of Spectaire shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is SPEC or THMO more profitable? ThermoGenesis' return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% ThermoGenesis N/A N/A N/A Does the media refer more to SPEC or THMO? In the previous week, Spectaire's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Spectaire Neutral ThermoGenesis Neutral Which has more risk and volatility, SPEC or THMO? Spectaire has a beta of -6.54, suggesting that its share price is 754% less volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500. SummaryThermoGenesis beats Spectaire on 6 of the 9 factors compared between the two stocks. Remove Ads Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$18,000.00$14.72B$20.09B$6.91BDividend YieldN/A3.37%2.90%4.23%P/E RatioN/A13.7636.5917.05Price / SalesN/A8.242,241.2785.96Price / CashN/A17.3834.5934.64Price / Book0.002.255.303.66Net Income$8.95M$538.63M$736.66M$247.27M7 Day PerformanceN/A-12.83%-8.96%-9.80%1 Month PerformanceN/A-12.32%50,332.47%-12.84%1 Year PerformanceN/A-20.95%52,810.75%-10.68% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.00flatN/A-99.9%$18,000.00N/A0.008THMOThermoGenesisN/AN/AN/AN/A$2,000.00$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.05-2.5%N/A-43.5%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01flatN/A+76.7%$0.00$25.56M0.001Positive NewsQSIAWQuantum-SiN/A$0.39-3.8%N/A+39.0%$0.00$3.06M0.00150Positive NewsGap DownSMAPWSportsMap Tech AcquisitionN/A$0.06-18.9%N/A+223.2%$0.00N/A0.00N/AGap DownTTTrane Technologies4.6556 of 5 stars$341.89+1.5%$413.69+21.0%+3.6%$76.68B$19.84B30.3939,000Dividend AnnouncementAnalyst ForecastPositive NewsGap UpKEYSKeysight Technologies4.6513 of 5 stars$149.93+0.1%$184.44+23.0%-19.7%$25.91B$5.02B42.8415,000Positive NewsGap UpFTVFortive4.7229 of 5 stars$73.50+0.4%$87.18+18.6%-25.6%$25.01B$6.23B31.1518,000Dividend AnnouncementAnalyst ForecastVLTOVeralto4.0089 of 5 stars$97.61+0.2%$113.50+16.3%-2.6%$24.16B$5.19B29.2316,000Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives FTV Alternatives VLTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPEC) was last updated on 4/9/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPEC Stock Free SPEC Stock Alerts